Structure of Piperaquine phosphate
CAS No.: 85547-56-4
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Piperaquine is a bisquinoline compound that is often used in combination with artimesinin for inhibition of HIV-1 replication. It inhibits the ex vivo growth of P. falciparum isolates from malaria-infected patients with IC50s ranging from 11.8-217.3 nM.
Synonyms: Piperaquine phosphate
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 85547-56-4 |
Formula : | C29H35Cl2N6O4P |
M.W : | 633.51 |
SMILES Code : | ClC1=CC=C2C(N3CCN(CCCN4CCN(C5=CC=NC6=CC(Cl)=CC=C56)CC4)CC3)=CC=NC2=C1.O=P(O)(O)O |
Synonyms : |
Piperaquine phosphate
|
MDL No. : | MFCD08457544 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01838902 | Malaria | Phase 3 | Completed | - | Gambia ... More >> Medical Research Council Unit (MRC), The Gambia Fajara, Gambia Less << |
NCT02802501 | Malaria, Vivax | Phase 3 | Recruiting | November 29, 2019 | Indonesia ... More >> GSK Investigational Site Recruiting Jakarta, Indonesia, 10430 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Less << |
NCT01288820 | Vivax Malaria | Phase 3 | Completed | - | Indonesia ... More >> Labuhan Batu Utara Regency Tanjung leidong village North Sumatra, North Sumatera, Indonesia Less << |
NCT02259426 | Malaria Asymp... More >>tomatic Malaria Plasmodium Falciparum Less << | Phase 3 | Completed | - | Kenya ... More >> ICIPE Mbita, Nyanza, Kenya, 30-40305 Less << |
NCT02324738 | Healthy | Phase 4 | Completed | - | Thailand ... More >> Faculty of Tropical Medicine Bangkok, Thailand, 10400 Less << |
NCT00393679 | Fever Malaria | Phase 3 | Completed | - | Burkina Faso ... More >> Centre Muraz/IRSS Bobo-Dioulasso, Burkina Faso Gabon Albert Schweitzer Hospital Lambaréné, Gabon Mozambique Manhiça Health Research Center Manhica, Mozambique Nigeria Hospital Calabar, Nigeria Rwanda Mashshesha and Rukara Kigali, Rwanda Uganda Jinja and Tororo Kampala, Uganda Mbarara, Mbarara, Uganda Zambia Tropical Diseases Research Centre, P O Box 71769, Ndola, Zambia Less << |
NCT00868465 | Uncomplicated Malaria | Not Applicable | Completed | - | Kenya ... More >> International Centre for Insect Physiology and Ecology - St. Judes Clinic Mbita, Suba District, Kenya Tanzania Kilimanjaro Christian Medical Centre, Magugu Field Site Moshi, Kilimanjaro Region, Tanzania Less << |
NCT02434952 | Malaria, Falciparum ... More >> G6PD Deficiency Less << | Phase 4 | Completed | - | Cambodia ... More >> Ratanakiri Provincial Hospital Ratanakiri, Cambodia Less << |
NCT03454048 | Malaria,Falciparum ... More >> Gametocytes Controlled Human Malaria Infection Transmission Less << | Not Applicable | Recruiting | December 1, 2018 | Netherlands ... More >> Radboud university medical center Recruiting Nijmegen, Gelderland, Netherlands, 6525 GA Contact: Isaie Reuling 024 361 9515 ext +31 isaie.reuling@radboudumc.nl Less << |
NCT01103830 | Malaria, Falciparum | Phase 1 | Completed | - | France ... More >> SGS aster s.a.s Paris, France, 75015 Less << |
NCT00941785 | Malaria | Phase 2 Phase 3 | Completed | - | Burkina Faso ... More >> IRSS Bobo-Dioulasso, Burkina Faso, BP545 Less << |
NCT03452475 | Plasmodium Falciparum | Phase 3 | Not yet recruiting | December 1, 2020 | - |
NCT02836002 | Malaria | Phase 1 Phase 2 | Completed | - | Netherlands ... More >> Radboud university medical center Nijmegen, Gelderland, Netherlands, 6525 GA Less << |
NCT02083380 | Uncomplicated Plasmodium Falci... More >>parum Malaria Less << | Phase 2 Phase 3 | Completed | - | Benin ... More >> Centre D'Étude Et de Recherchesur Le Paludisme Associé À La Grossesse Et À L'Enfance (Cerpage) Cerpage Cotonou, Benin, FSS 01 BP 188 Burkina Faso Centre National de Recherche et de Formation sur le paludisme (CNRFP) Ouagadougou, Kadiogo Ouagadougou, Burkina Faso Clinical research Unit of Nanoro (CRUN)/CMA Saint Camille de Nanoro, 11 BP 218 Ouagadougou CMS 11 Ouagadougou, Burkina Faso Congo, The Democratic Republic of the Kinshasa School of Public Health, School of Medicine University of Kinshasa Kinshasa, Congo, The Democratic Republic of the Gabon Centre de Recherches Medicales de Lambarene, Albert Schweitzer Hospital Lambarene, Gabon arielle K. Bouyou-Akotet, Department of Parasitology-Mycology and Tropical Medicine, Faculty of Medicine, Université des Sciences de la Santé, BP 4009, Libreville, Gabon Libreville, Gabon Mozambique MANHIÇA HEALTH RESEARCH CENTER, Rua 12, Vila da Manhica, Maputa, Chefe Maputa, Mozambique Uganda Tororo District Hospital Tororo, Uganda Vietnam National Institute of Malariology, Parasitology and Entomology, 245 Luong The Vinh Street, Trung van, Tu Liem, Hanoi, Vietnam Hanoi, Vietnam Less << |
NCT01887821 | Plasmodium Vivax Malaria | Phase 4 | Completed | - | Vietnam ... More >> Bu Gia Map Health Station Bu Gia Map, Binh Phuoc, Vietnam Less << |
NCT00852423 | Malaria in Pregnancy | Phase 3 | Completed | - | Burkina Faso ... More >> ISSR/Centre Muraz Nanoro, Burkina Faso ISSR/Centre Muraz Nazoanga, Burkina Faso Ghana Kwame Nkrumah University of Science & Technology, Kumasi Ejisu Sekyere East, Ashanti Region, Ghana Kwame Nrumah University of Science and Technology, Kumasi Juaben Government Hospital, Ashanti Region, Ghana Effiduase Government Hospital Effiduase, Ghana Malawi College of Medicine, University of Malawi Chikwawa District Hospital, Blantyre, Malawi Zambia St Paul Hospital Nchelenge, Nchelenge District, Zambia Less << |
NCT00529620 | Malaria | Phase 3 | Completed | - | Senegal ... More >> Departement de Parasitologie et Mycologie, Universite Cheikh Anta Diop Dakar, Senegal Less << |
NCT03697668 | Plasmodium Falciparum Malaria ... More >>(Drug Resistant) Less << | Phase 2 | Recruiting | December 31, 2019 | Vietnam ... More >> A Tuc Recruiting Hương Hóa, Quang Tri, Vietnam, 520000 Contact: Tuan A Tran, MD +84982290426 tuanhuonghoa@gmail.com Less << |
NCT02083380 | - | Completed | - | - | |
NCT01222949 | Malaria, Falciparum | Phase 1 | Completed | - | Australia ... More >> CMAX, a division of IDT Australia Limited Adelaide, Australia, SA 5000 Nucleus Network Limited Melbourne, Australia, VIC 3004 Less << |
NCT01525511 | Healthy | Phase 1 | Completed | - | Thailand ... More >> Hospital of Tropical Diseases, Faculty of Tropical Medicine, Mahidol University Bangkok, Thailand, 10400 Less << |
NCT02431650 | Malaria | Phase 1 Phase 2 | Completed | - | Australia, Queensland ... More >> Q-Pharm Clinics Herston, Queensland, Australia, 4006 Less << |
NCT02788864 | Malaria | Phase 4 | Completed | - | Vietnam ... More >> Bu Gia Map Commune Health Station Binh Phuoc, Vietnam, 830000 Less << |
NCT02974348 | Drug Resistant Malaria Due to ... More >>Plasmodium Falciparum Less << | Phase 3 | Completed | - | Cameroon ... More >> CDC Hospital Tiko, South west, Cameroon, 237 Less << |
NCT02575755 | Pregnancy Inf... More >>ections, Plasmodia Drug Kinetics Clinical Efficacy Less << | Phase 4 | Unknown | October 2016 | Papua New Guinea ... More >> Papua New Guinea Institute of Medical Research Recruiting Madang, Madang Province, Papua New Guinea, 511 Contact: Brioni R Moore, BSc, PhD (+61) 0466266334 brioni.moore@uwa.edu.au Contact: Leanne J Robinson, BSc, PhD, MPH (+675) 422 2909 robinson@wehi.edu.au Less << |
NCT02543086 | Plasmodium Falciparum Malaria | Phase 1 | Terminated | - | Australia, Queensland ... More >> Novartis Investigative Site Brisbane, Queensland, Australia, 4006 Less << |
NCT01930331 | Plasmodium Falciparum ... More >> Malaria, Falciparum Less << | Phase 4 | Completed | - | Tanzania ... More >> Ifakara Health Institute Bagamoyo, Tanzania, 74 Less << |
NCT02461186 | Uncomplicated Falciparum Malar... More >>ia Artemisinin-resistant Less << | Phase 2 Phase 3 | Withdrawn(Change of the study ... More >>site due to the current political climate in Myanmar.) Less << | June 2017 | - |
NCT03542149 | Malaria | Phase 1 | Recruiting | July 15, 2019 | Australia, Queensland ... More >> Q-Pharm Recruiting Herston, Queensland, Australia, 4006 Contact: Brenda Cerqueira, MSc +61 (0) 439 726 233 B.Cerqueira@qpharm.com.au Contact: Priscila White, MSc +61 (0) 439 726 233 P.White@qpharm.com.au Less << |
NCT01853475 | Malaria | Phase 1 | Completed | - | United Kingdom ... More >> Richmond Pharmacology Limited Croyden, London, United Kingdom, CR7 7YE Less << |
NCT01853475 | - | Completed | - | - | |
NCT02387580 | - | Completed | - | - | |
NCT02083406 | Malaria | Phase 1 | Completed | - | United Kingdom ... More >> Quotient Clinical Nottingham, Nottinghamshire, United Kingdom, NG11 6JS Less << |
NCT02083406 | - | Completed | - | - | |
NCT02431637 | Malaria | Phase 1 | Completed | - | Australia, Queensland ... More >> Q-Pharm Clinics Herston, Queensland, Australia, 4006 Less << |
NCT01958619 | Malaria | Phase 1 | Completed | - | United Kingdom ... More >> Richmond Pharmacology Ltd. Croydon, London, United Kingdom, CR7 7YE Less << |
NCT02198807 | Oral Treatment of Acute Uncomp... More >>licated Plasmodium Falciparum Malaria Less << | Phase 2 | Unknown | December 2015 | - |
NCT01958619 | - | Completed | - | - | |
NCT02387580 | Malaria | Phase 1 | Completed | - | United Kingdom ... More >> Quotient Clinical Nottingham, Nottinghamshire, United Kingdom, NG11 6JS Less << |
NCT01222962 | Malaria, Falciparum | Phase 1 | Completed | - | Australia ... More >> CMAX, a division of IDT Australia Limited Adelaide, Australia, SA 5000 Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.58mL 0.32mL 0.16mL |
7.89mL 1.58mL 0.79mL |
15.79mL 3.16mL 1.58mL |
Tags: Piperaquine phosphate | Antiparasitic | Anti-Infection | 85547-56-4
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL